Amgen Inc.

NASDAQ: AMGN · Real-Time Price · USD
293.06
2.77 (0.95%)
At close: Aug 15, 2025, 9:57 AM

Amgen Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
33.42B 28.19B 26.32B 25.98B
Cost of Revenue
12.86B 8.41B 6.41B 6.45B
Gross Profit
20.57B 19.77B 19.92B 19.52B
Operating Income
7.26B 7.9B 9.57B 7.64B
Interest Income
n/a n/a n/a n/a
Pretax Income
4.61B 7.86B 7.35B 6.7B
Net Income
4.09B 6.72B 6.55B 5.89B
Selling & General & Admin
7.1B 6.18B 5.41B 5.37B
Research & Development
5.96B 4.78B 4.43B 4.82B
Other Expenses
248M 879M 503M 1.7B
Operating Expenses
13.31B 11.84B 10.35B 11.89B
Interest Expense
3.15B 2.88B 1.41B 1.2B
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
26.17B 20.29B 16.76B 18.34B
Income Tax Expense
519M 1.14B 794M 808M
Shares Outstanding (Basic)
541M 535M 538M 570M
Shares Outstanding (Diluted)
541M 538M 541M 573M
EPS (Basic)
7.56 12.56 12.18 10.34
EPS (Diluted)
7.56 12.49 12.11 10.28
EBITDA
13.36B 14.8B 12.17B 11.3B
EBIT
7.76B 10.73B 8.75B 7.9B
Depreciation & Amortization
5.59B 4.07B 3.42B 3.4B